Skip to main content

Ondansetron Tablets

Type of Posting: Revision Bulletin

Posting Date: 30–Jun–2010

Official Date: 01–Aug–2010

Expert Committee: Biopharmaceutics Expert Committee

In accordance with the Rules and Procedures of the 2005–2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the Ondansetron Tablets monograph. The purpose for the revision is to include Dissolution Test 5.

The Ondansetron Tablets Monograph Revision Bulletin supersedes the currently official Ondansetron Tablets Monograph. The Revision Bulletin will be incorporated in USP 34–NF 29.

Should you have any questions, please contact Margareth Marques, Ph.D. (301-998-8106 or mrm@usp.org).